Skip to main content
RPID
NASDAQ Industrial Applications And Services

Rapid Micro Biosystems Prices $9.8M Offering with Warrants, D&Os Participate

Analysis by Arik Shkolnikov
Sentiment info
Negative
Importance info
8
Price
$1.9
Mkt Cap
$90.619M
52W Low
$1.9
52W High
$4.94
Market data snapshot near publication time

summarizeSummary

Rapid Micro Biosystems priced a public offering of common stock and warrants to raise $8.9 million net, with potential for an additional $21.7 million from warrant exercises, leading to significant dilution for shareholders.


check_boxKey Events

  • Public Offering Priced

    The company priced a public offering of 3,581,000 shares of Class A common stock and pre-funded warrants to purchase 1,463,000 shares, each bundled with Series A and Series B common stock warrants.

  • Significant Capital Raise

    The offering is expected to generate approximately $8.9 million in net proceeds for the company, with a potential for an additional $21.7 million if all Series A and Series B warrants are exercised in cash.

  • Substantial Dilution

    New investors will experience an immediate dilution of $1.30 per share. The full exercise of all warrants could lead to a potential dilution of over 33% of current outstanding shares.

  • Insider Participation

    Certain directors and officers are participating in a concurrent registered direct offering, agreeing to purchase approximately $140,000 worth of shares and accompanying warrants at the same terms.


auto_awesomeAnalysis

Rapid Micro Biosystems has finalized the terms of a significant capital raise, offering common stock and pre-funded warrants bundled with Series A and Series B warrants. While this offering provides crucial capital for working capital and general corporate purposes, especially following a Q1 2026 report of wider net losses and increased cash burn, it comes at a substantial cost to existing shareholders. The immediate dilution of $1.30 per share for new investors, coupled with the potential for over 33% dilution if all warrants are exercised, indicates a challenging financial position. The offering is priced at the last reported sale price but near the company's 52-week low, suggesting a pressing need for funds. Although directors and officers are participating with a $140,000 purchase, this is a small fraction of the total capital being raised.

At the time of this filing, RPID was trading at $1.90 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $90.6M. The 52-week trading range was $1.90 to $4.94. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed RPID - Latest Insights

RPID
May 19, 2026, 5:23 PM EDT
Source: Wiseek News
Importance Score:
8
RPID
May 19, 2026, 5:13 PM EDT
Filing Type: 8-K
Importance Score:
8
RPID
May 19, 2026, 5:12 PM EDT
Filing Type: 424B5
Importance Score:
8
RPID
May 19, 2026, 5:10 PM EDT
Filing Type: 424B5
Importance Score:
8
RPID
May 18, 2026, 9:56 PM EDT
Source: Reuters
Importance Score:
9
RPID
May 15, 2026, 7:35 AM EDT
Filing Type: 10-Q
Importance Score:
8
RPID
May 13, 2026, 4:33 PM EDT
Filing Type: 8-K
Importance Score:
8
RPID
May 13, 2026, 4:27 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
RPID
Apr 08, 2026, 4:36 PM EDT
Filing Type: DEF 14A
Importance Score:
7
RPID
Mar 27, 2026, 4:34 PM EDT
Filing Type: 8-K
Importance Score:
7